ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /化合物

ビタミンB12

Anacobin

HCID 5311498
反応を作成
印刷
基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
部分構造検索類似構造を探す

基本情報

CAS
68-19-9
標準SMILES
C/C1=C2N=C(/C=C3N=C(/C(C)=C4\[N-][C@@](C)([C@@H]5N=C1[C@](C)(CCC(=O)NC[C@@H](C)OP(=O)([O-])O[C@H]1[C@@H](O)[C@@H](n6cnc7cc(C)c(C)cc76)O[C@@H]1CO)[C@H]5CC(N)=O)[C@@](C)(CC(N)=O)[C@@H]4CCC(N)=O)[C@@](C)(CC(N)=O)[C@@H]\3CCC(N)=O)C(C)(C)[C@@H]/2CCC(N)=O.[C-]#N.[Co+3]
InChIKey
FDJOLVPMNUYSCM-WZHZPDAFSA-L
分子式
C63H88CoN14O14P
平均分子量
1,355.4 g/mol
単同位体質量
1,354.567399

概要

Cyanocobalamin (commonly known as Vitamin B12) is a highly complex, essential vitamin, owing its name to the fact that it contains the mineral, cobalt. This vitamin is produced naturally by bacteria, and is necessary for DNA synthesis and cellular energy production. Vitamin B12 has many forms, including the cyano-, methyl-, deoxyadenosyl- and hydroxy-cobalamin forms. The cyano form, is the most widely used form in supplements and prescription drugs,. Several pharmaceutical forms of cyanocobalamin have been developed, including the tablet, injection, and nasal spray forms,,. This drug was initially approved by the FDA in 1942.

名称と識別子

優先名称
Anacobin
IUPAC
cobalt(3+);[(2R,3S,4R,5S)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2R)-1-[3-[(1R,2R,3R,5Z,7S,10Z,12S,13S,15Z,17S,18S,19R)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7,12,17-tetrahydro-1H-corrin-24-id-3-yl]propanoylamino]propan-2-yl] phosphate;cyanide
現地名
ビタミンB12
英語名
Vitamin B12
分子式
C63H88CoN14O14P
分子量
1355.37

名称と別名

Vitamin B??AnacobinDTXCID5024346Cyanocobalamin;Cyanocob(III)alaminCAS-68-19-9CYANOCOBALAMIN 0.1% IN MANNITOLNCGC00016302-01Prestwick_564Vitamin B12 NOSVitamin B12 (charged)Vitamin B12 MethylcobalaminMSK1508
名称をさらに表示
ビタミンB12シアノコバラミンビタミンB12標準品シアノコバラミン標準品ビタミン B12(シアノコバラミン)シアノコバラミン (JP17)CYANOCOBALAMINVb12METHYLCOBALAMINCYANOCOBALAMINEhemomincyanocobalamin (b12)COBALAMINEhydroxycobalamin chlorideVIT B12depinar
HMS1569G08HMS2096G08HMS3713G08Tox21_110358Tox21_113664AKOS015894306AKOS037515760CCG-220433

データベース識別子

CAS

物性

構造計算による物性

極性表面積
476 Ų
水素結合供与体数
9
水素結合受容体数
21
回転可能結合数
26
重原子数
93
形式電荷
0
複雑度
3,220

実験および物理化学的性質

Boiling Point> 300
Melting Point> 300
Dissociation Constants1.84, 8.77
Collision Cross Section337.8 Ų [M-H]-

物理化学的性質

融点
300 °C · >300°C
比旋光度
23656 · 23656 -59 ± 9° (dil aq soln)
沸点
300 °C · >300 °C
闪点
9 ℃ · 9℃
貯蔵温度
2 · 2-8°C
溶解性
96 %)に溶けにくく、アセトンにはほとんど溶けない。無水物質は非常に吸湿性があります。 · 水およびエタノール(96%)に溶けにくく、アセトンにはほとんど溶けない。無水物質は非常に吸湿性があります。
外見
結晶性粉末または結晶
酸解離定数(Pka)
3.28 · pKa 3.28±0.04(H2O,D2O t=23±0.5 Iunspecied) (Uncertain)
色
赤から濃い赤
PH
6 · 6.0 (20°C, 1g/L in H2O)
臭い (Odor)
暗赤色の結晶。または粉末、無臭無味
由来生物
synthetic ((organic))
水溶解度
溶ける

安全と法規制

安全情報は参考情報です。供給元の安全データシート(SDS)、適用法令、専門家による評価に代わるものではありません。

安全データ

wgk
WGK 1
tsca
TSCA listed
毒性
LD50 intravenous in mouse: 2gm/kg
PRTR法
第一種指定化学物質
hs_code
2936260000
安衛法
57,57-2
ストレージクラス
11 - Combustible Solids
有毒物質データの
68-19-9(Hazardous Substances Data)

化学と産業

薬理情報

Protein BindingVery high (to specific plasma proteins called transcobalamins); binding of hydroxocobalamin is slightly higher than cyanocobalamin [FDA label.
Pharmacodynamics · 1 件

**General effects** Cyanocobalamin corrects vitamin B12 deficiency and improves the symptoms and laboratory abnormalities associated with pernicious anemia (megaloblastic indices, gastrointestinal lesions, and neurologic damage). This drug aids in growth, cell reproduction, hematopoiesis, nucleoprotein, and myelin synthesis. It also plays an important role in fat metabolism, carbohydrate metabolism, as well as protein synthesis. Cells that undergo rapid division (for example, epithelial cells, bone marrow, and myeloid cells) have a high demand for vitamin B12. **Parenteral cyanocobalamin effects** The parenteral administration of vitamin B12 rapidly and completely reverses the megaloblastic anemia and gastrointestinal symptoms of vitamin B12 deficiency. Rapid parenteral administration of vitamin B12 in deficiency related neurological damage prevents the progression of this condition. **Nasal spray effects** In 24 vitamin B12 deficient patients who were already stabilized on intramuscular (IM) vitamin B12 therapy, single daily doses of intranasal cyanocobalamin for 8 weeks lead to serum vitamin B12 concentrations that were within the target therapeutic range (>200 ng/L).

Mechanism of Action · 1 件

Vitamin B12 serves as a cofactor for _methionine synthase_ and _L-methylmalonyl-CoA mutase_ enzymes. Methionine synthase is essential for the synthesis of purines and pyrimidines that form DNA. L-methylmalonyl-CoA mutase converts L-methylmalonyl-CoA to _succinyl-CoA_ in the degradation of propionate, an important reaction required for both fat and protein metabolism. It is a lack of vitamin B12 cofactor in the above reaction and the resulting accumulation of methylmalonyl CoA that is believed to be responsible for the neurological manifestations of B12 deficiency. Succinyl-CoA is also necessary for the synthesis of hemoglobin. In tissues, vitamin B12 is required for the synthesis of _methionine_ from homocysteine. Methionine is required for the formation of S-adenosylmethionine, a methyl donor for nearly 100 substrates, comprised of DNA, RNA, hormones, proteins, as well as lipids. Without vitamin B12, tetrahydrofolate cannot be regenerated from 5-methyltetrahydrofolate, and this can lead to functional folate deficiency,. This reaction is dependent on methylcobalamin (vitamin B12) as a co-factor and is also dependent on folate, in which the methyl group of methyltetrahydrofolate is transferred to homocysteine to form _methionine_ and _tetrahydrofolate_. Vitamin B12 incorporates into circulating folic acid into growing red blood cells; retaining the folate in these cells. A deficiency of vitamin B12 and the interruption of this reaction leads to the development of megaloblastic anemia.

関連反応

18 件
反応記録を作成
HRID 431181 の反応式
HRID 431181反応物として
HRID 431182 の反応式
HRID 431182反応物として
HRID 431183 の反応式
HRID 431183反応物として
HRID 431184 の反応式
HRID 431184反応物として
HRID 431185 の反応式
HRID 431185反応物として
HRID 431186 の反応式
HRID 431186反応物として
HRID 431187 の反応式
HRID 431187反応物として
HRID 431188 の反応式
HRID 431188反応物として
前へ1 / 3 ページ

化合物ノート

このページの内容基本情報概要名称と識別子物性安全と法規制化学と産業関連反応化合物ノート
68-19-9
PubChem CID
5311498
Merck
14 · 14,10014
BRN
4122889 · 4122889
安定性
吸湿性。寒さと乾燥を保ちます。
化粧品成分の機能
スキンコンディショニング
InChIKey
RMRCNWBMXRMIRW-WZHZPDAFSA-L
LogP
3.57 · 3.570 (est)
EPAの化学物質情報
12 · Vitamin B12 (68-19-9)

化学的性質

化学的特性Dark red, crystalline powder or dark red crystals.

Biological Half-LifeApproximately 6 days (400 days in the liver).
Metabolism/Metabolites · 1 件

Vitamin B12 or cyanocobalamin obtained from food is initially bound by _haptocorrin_, a protein found in the saliva with high affinity for B12. This forms a _haptocorrin-B12_ complex. Cyanocobalamin passes through the stomach and is protected from acid degradation due to its binding to haptocorrin. In the duodenum, pancreatic _proteases_ release cobalamin from the _haptocorrin-B12 complex_ and from other proteins containing protein-bound B12 that have been ingested. Following this, the binding of cobalamin to a second glycoprotein, _intrinsic factor_, promotes its uptake by terminal ileum mucosal cells by a process called _cubilin_/AMN receptor-mediated endocytosis. After absorption into enterocytes, intrinsic factor is broken down in the lysosome, and cobalamin is then released into the bloodstream. The transporter ABCC1, found in the basolateral membrane of intestinal epithelial and other cells, exports cobalamin bound to transcobalamin out of the cell. Cyanocobalamin then passes through the portal vein in the liver, and then reaches the systemic circulation. The active forms of cyanocobalamin are _methylcobalamin_ and _adenosylcobalamin_,.

Absorption, Distribution and Excretion · 4 件

Vitamin B12 is quickly absorbed from intramuscular (IM) and subcutaneous (SC) sites of injection; with peak plasma concentrations achieved about 1 hour after IM injection. Orally administered vitamin B12 binds to intrinsic factor (IF) during its transport through the stomach. The separation of Vitamin B12 and IF occurs in the terminal ileum when calcium is present, and vitamin B12 is then absorbed into the gastrointestinal mucosal cells. It is then transported by transcobalamin binding proteins. Passive diffusion through the intestinal wall can occur, however, high doses of vitamin B12 are required in this case (i.e. >1 mg). After the administration of oral doses less than 3 mcg, peak plasma concentrations are not reached for 8 to 12 hours, because the vitamin is temporarily retained in the wall of the lower ileum.

This drug is partially excreted in the urine. According to a clinical study, approximately 3-8 mcg of vitamin B12 is secreted into the gastrointestinal tract daily via the bile. In patients with adequate levels of intrinsic factor, all except approximately 1 mcg is reabsorbed. When vitamin B12 is administered in higher doses that saturate the binding capacity of plasma proteins and the liver, the unbound vitamin B12 is eliminated rapidly in the urine. The body storage of vitamin B12 is dose-dependent.

Cobalamin is distributed to tissues and stored mainly in the liver and bone marrow.

During vitamin loading, the kidney accumulates large amounts of unbound vitamin B12. This drug is cleared partially by the kidney, however, multiligand receptor _megalin_ promotes the reuptake and reabsorption of vitamin B12 into the body,.

応用分野 · 6 件

解説シアノコバラミン,ビタミン B12 ともいう.肝臓の水性エキス中に含まれる水溶性抗悪性貧血因子の主要成分で,葉酸の発見(1945年)についで,E. Rickes,E.L. Smithらによって単離された.化学構造は三価のコバルト1原子を含むことが特徴で,この Co3+ に多数の側鎖を有するポルフィリン核,CN基,およびヌクレオチドが結合し,さらにこのヌクレオチドは1-アミノ-2-プロパノールをなか立ちとしてポルフィリンに結合した構造をもっている.暗赤色の針状または細長い板状の吸湿性結晶.210~220 ℃ で黒変し,300 ℃ に達しても融解しない.水,アルコール類に可溶,アセトン,クロロホルム,エーテルに不溶.水溶液は278,361,548 nm に吸収極大をもつ.コバルトに配位しているCN-のかわりにアデノシンが結合すると補酵素 B12(cobamide)となる.この補酵素は細菌でグルタミン酸のβ-メチルアスパラギン酸への転換を触媒し,また動物組織では,メチルマロニルCoAからスクシニルCoAを生じるイソメラーゼ反応を触媒する.また,大腸菌のメチオニン合成にも別の B12 含有酵素が関与するといわれる.ヒトにおけるビタミン B12 欠乏症は,巨赤芽球性貧血(悪性貧血),あるいは神経系障害を呈する.

用途ビタミン B12 化合物です。 メチル基転移反応、カルボキシル基の分子内 転移反応に関与しています。

用途ビタミン B12 化合物です。メ チル基転移反応、カルボキシル基の分子内転 移反応に関与しています

来歴VITAMIN B12 (Cobalamin), Sometimes also called cyanocobalamin, this vitamin is one of the more recent of the major B complex vitamins to be fully identified, with its structure not definitized (by Hodkin et al.)

使用Prototype of the family of naturally occurring cobalt coordination compounds knows as corrinoids. Analogs of vitamin B12 which differ only in the β-ligand of the cobalt are termed cobalamins. Synthesi zed almost exclusively by bacteria. Dietary sources include fish, meat, liver, and dairy products; plants have little or no cobalamins. Converted by the body into its bioactive forms, methylcobalamin and cobamamide, which serve as enzyme cofactors. Severe deficiency may result in megaloblastic anemia and/or neurological impairment.

一般的な説明Pharmaceutical secondary standards for application in quality control, provide pharma laboratories and manufacturers with a convenient and cost-effective alternative to the preparation of in-house working standards.Cyanocobalamin, also known as vitamin B12, belongs to a group of organic compounds important for the normal growth and development of human and animal bodies. It is used for the treatment of trigeminal neuralgia and multiple sclerosis.

調製方法

Vitamin B12 dietary supplements are often prepared commercially by the fermentation of S. griseus, S. aureofaciens, Propionibacterium; or as a by-product of antibiotic production.

上流・下流製品情報

上流原料

5,6-ジメチルベンゾイミダゾールgray鉛(II)オキシドstreptomyces avermifilis2-メチルベンゾイミダゾールCyanide, Quant Test StripsCation exchange resin,weak acidic acrylic acid塩化コバルト(II)corn syrup

下流製品

メコバラミン

補足説明

定義本品は、ビタミンB12であり、次の化学式で表される。